First experiences with fluorodeoxyglucose-positron-emission tomography (FDG-PET) in the evaluation of painful total knee and hip joint replacements;Erste erfahrungen mit der fluorodeoxyglukose-positronenemissionstomographie (FDG-PET) in der diagnostik schmerzhafter knie- und hüfttotalendoprothesen

Zeitschrift fur Orthopadie und Ihre Grenzgebiete

Volumn 141, Issue 2, 2003, Pages 153-159

  Kisielinski, K ^a   Cremerius, U ^a   Bull U ^a   Hermanns, B ^a   Wirtz, D C ^a   Niethard, F U ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Arthroplasty infection; Aseptic loosening; FDG PET; Total hip joint replacement; Total knee joint replacement

Indexed keywords

FLUORODEOXYGLUCOSE F 18; POLYETHYLENE; DIAGNOSTIC AGENT;

ADULT; AGED; ARTHROPLASTY; ARTICLE; CLINICAL ARTICLE; FOREIGN BODY REACTION; GRANULATION TISSUE; HISTOPATHOLOGY; HUMAN; MICROBIOLOGICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PROSTHESIS INFECTION; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; FEMALE; GLUCOSE BLOOD LEVEL; HIP; HIP ARTHROPLASTY; INFECTION; KNEE; KNEE ARTHROPLASTY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROSTHESIS FAILURE; SCINTISCANNING;

AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD GLUCOSE; FEMALE; FLUORODEOXYGLUCOSE F18; FOREIGN-BODY REACTION; HIP JOINT; HUMANS; KNEE JOINT; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSTHESIS FAILURE; PROSTHESIS-RELATED INFECTIONS;

EID: 0037690749     PISSN: 00443220     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-38649     Document Type: Article

References (44)

1. Charnley J. Total hip replacement by low-friction arthroplasty. Clin Orthop 1970; 72: 7-21
2. Kobayashi A, Freeman MAR, Bonfield W, Kadoya Y, Yamac T. Number of polyethylene particles and osteolysis in total joint replacement. J Bone Joint Surg 1997; 79-B : 844-848
3. Wright TM, Rimnac CM, Stulberg SD, Mintz L, Tsao AK, Klein RW, McCrae C. Wear of polyethylene in total joint replacements. Observations from retrieved PCA knee implants. Clin Orthop 1992; 276: 126-134
4. Revell PA, Weightman B, Freeman MAR, Roberts BV. The production and biology of polyethylene wear debris. Arch Orthop Trauma Surg 1978; 91: 167-181
5. Charosky CB, Bullough PG, Wilson PD. Total hip replacement failures histological evaluation. J Bone Joint Surg 1973; 55-A : 49-58
6. Mirra JM, Amstutz HC, Matos M, Gold R. The pathology of the joint tissues and its clinical relevance in prosthesis failure. Clin Orthop 1976; 117: 221-240
7. Willert HG, Semlitsch M. Reactions of the articular joint capsule to wear products of artificial joint prostheses. J Biomed Mater Res 1977; 11: 157-164
8. Kabo JM, Gebhard JS, Loren G, Amstutz H. In vivo wear of polyethylene acetabular components. J Bone Joint Surg 1993; 75-B : 254-258
9. Haynes DR, Crotti TN, Potter AE, Loric M, Atkins GJ, Howie DW, Findlay DM. The osteoclastogenic molecules RANKL and RANK are associated with periprostetic osteolysis. J Bone Joint Surg 2001; 83-B : 902-911
10. Kadoya Y, Kobashi A, Ohashi H. Wear and osteolysis in total joint replacements. Acta Orthop Scand 1998; 68 (suppl 278): 1-16
11. Willert HG, Bretram H, Buchhorn GH. Osteolysis in alloarthroplasty of the hip: the role of ultra-high molecular weight polyethylene wear particles. Clin Orthop 1990; 258: 95-107
12. Howie DW, Vernon-Roberts B, Oakeshott R, Manthey B. A rat model of absorption of bone at the cement-bone interface in the presence of polyethylene wear particles. J Bone Joint Surg 1988; 70-A : 257-262
13. Wroblewski BM. Wear of high-density polyethylene on bone and cartilage. J Bone Joint Surg 1979; 61-B : 498-500
14. Webb PJ, wright KWJ, Winter GD. The monk "soft top" endoprosthesis. Clinical, biomechanical, and histopathological observations. J Bone Joint Surg 1980; 62B : 174-179
15. Goldring SR, Clark CR, Wright TM. Editorial. The problem in total joint arthroplasty: aseptic loosening. J Bone Joint Surg 1993; 75-A: 799-801
16. Kadoya Y, Revell PA, Kobayashi A. Wear particulate species and bone loss in failed total joint arthroplasties. Clin Orthop 1997; 340: 118-129
17. Harris WH. Osteolysis and particle disease in hip replacement: a review. Acta Orthop Scand 1994; 65: 112-123
18. Sanzen L, Sundberg M. Periprosthetic low-grade hip infections. Erythrocyte sedimentation rate and C-reactive protein in 23 cases. Acta Orthop Scand 1997; 68: 461-465
19. Fehring TK, Cohen B. Aspiration as a guide to sepsis in revision total hip arthroplasty. J Arthroplasty 1996; 11: 3543-3547
20. Barrack RI, Harris WH. The value of aspiration of the hip joint before revision total hip joint arthroplasty. J Bone Joint Surg Am 1993; 75: 66-67
21. Ryan PJ, Fogelman I. The role of nuclear medicine in orthopaedics. Nucl Med Comm 1994; 15: 341-360
22. Tehranzedeh J, Gubernick I, Blaha D. Prospective study of sequential technetium-99 m phosphate and gallium imaging in painful hip prostheses (comparison of diagnostic modalities). Clin Nucl Med 1988; 13: 229-235
23. Petersen MM, Madsen JL, Pedersen F, Jensen JS, Rossing N. Bone scintigraphy in patients with hip joint prostheses. Use of bone scintigraphy in hip pain after total hip replacement. Ugeskr Laeger 1989; 151: 940-941
24. 18F-Fluoride Ion and PET. J Comput Assist Tomo 1993; 17: 34-41
25. Schmitz A, Risse HJ, Kalicke T, Grunwald F, Schmitt O. FDG-PET zur Diagnostik und Verlaufskontrolle entzündlicher Prozesse: Erste Ergebnisse aus orthopädischer Sicht. Z Orthop 2000; 138: 407-412
26. Guhlmann A, Brecht-Krauss D, Suger G, Glatting G, Kotzerke J, Kinzl L, Reske SN. Chronic Osteomyelitis: detection with FDG-PET and correlative histopathologic findings. Radiology 1998; 206: 746-754
27. Zhuang H, Duarte PS, Pourdehand M, Shnier D, Alavi A. Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging. Clin Nucl Med 2000; 25 (4): 281-284
28. Strauss LG, Conti PS. The application of PET in clinical oncology. J Nucl Med 1991; 32: 623-648
29. Rennen HJJM, Boerman OC, Oyen WJG, Corstens FHM. Imaging infection/inflammation in the new millenium. Eur J Nucl Med 2001; 28: 241-252
30. Stumpe KDM, Dazzi H, Schaffner A, von Schultheiss GK. Infection imaging using whole-body FDG-PET. Eur J Nucl Med 2000; 27: 822-832
31. Kälicke T, Schmitz A, Risse JH, Arens S, Keller E, Hansis M, Schmitt O, Biersack HJ, Grünwald F. Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: results of histologically confirmed cases. Eur J Nucl Med 2000; 27: 524-528
32. 18F-fluoro-2-deoxy-D-glucose. Radiology 1996; 200: 243-247
33. Grunwald F, Schomburg A, Bender H, Klemm E, Menzel C, Bultmann T, Palmedo H, Ruhlmann J, Kozak B, Biersack HJ. Fluorine-18-FDG-PET in the follow up of differentiated thyroid cancer. Eur J Nucl Med 1996; 23: 312-319
34. Rigo P, Paulus P, Kaschten BJ, Hustinx R, Bury T, Jerusalem G, Benoit T, Foidart-Willems J. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxy-glucose. Eur J Nucl Med 1996; 23: 1614-1674
35. Bax JJ, Valkema R, Visser FC, Poldermans D, Cornel JH, van Lingen A, Krenning EP, Rambaldi R, Roelandt JR, Visser CA, Fioretti PM. Detection of myocardial viability with F-18-fluorodeoxyglucose and single photon emissioncomputed tomography. G Ital Cardiol 1997; 27: 1181-1186
36. Piert M, Koeppe RA, Giordani B, Minoshima S, Kuhl DE. Determination of of regional rate constants from dynamic FDG-PET studies in Parkinsońs disease. J Nucl Med 1996; 37: 1115-1122
37. Van Acker F, Nuyts J, Maes A, Vanquickenborne B, Stuyck J, Bellemans J, Vleugels S, Bormans G, Mortelmans L. FDG-PET, Tc-HMPAO white blood cell SPET and bone scintigraphy in the evaluation of painful total knee arthroplasties. Eur J Nucl Med 2001; 28: 1478-1504
38. De Winter F, Van de Wiele C, Vogelaers D, De Smet K, Verdonk R, Dierckx RA. Fluorine-18 fluorodeoxyglucose-positron emission tomography: a highly accurate imaging modality for the diagnosis of chronic musculosceletal infections. J Bone Joint 2001; 83-A : 651-660
39. Zhuang H, Duarte PS, Pourdehnad M, Maes A, Van Acker F, Shnier D, Garino JP, Fitzgerald RH, Alavi A. The promising role of FDG-PET in detecting infected lower limb prosthesis implants. J Nucl Med 2001; 42: 44-48
40. Larson RL. Rating sheet for knee function. In: Smillie I, editor. Diseases of the knee joint. Edingburgh: Churchill Livingstone, 1974: 28-20
41. Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end result study using a new method of result evaluation. J Bone Joint Surg 1969; 51-A : 737-755
42. Ichiya Y, Kuwabara Y, Sasaki M, Yoshida T, Akashi Y, Murayama S, Nakamura K, Fukumura T, Masuda K. FDG-PET in infectious lesions: The detection and assessment of lesion activity. Ann Nucl Med 1996; 10: 185-191
43. Sugawara Y, Braun D, Kison P, Russo J, Zasadny K, Wahl R. Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results. Eur J Nucl Med 1998; 25: 1238-1243
44. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33: 1972-1980